DelSiTech Ltd will participate virtually in the ChinaBio® Partnering Forum 2026, which will take place on 28-29 April in Shanghai, China, followed by virtual partnering on 6–7 May 2026.
The event focuses on cross‑border partnering between global and Chinese biotech and pharmaceutical companies. We will engage to explore collaboration opportunities around its silica‑based drug delivery platform enabling long‑acting injectable formulations across multiple therapeutic areas, including Metabolic Disease and Post Operative Pain.
Meetings can be arranged with our Business Development and Alliance Management team via the ChinaBio® partnering platform or bd@delsitech.com.